GJB2 Gene Keratitis Ichthyosis Deafness Syndrome Autosomal Dominant NGS Genetic DNA Test
Introduction
The GJB2 Gene Keratitis Ichthyosis Deafness Syndrome Autosomal Dominant NGS Genetic DNA Test is a crucial diagnostic tool that helps in identifying genetic mutations related to keratitis ichthyosis deafness syndrome (KID syndrome). This condition is characterized by a combination of skin and hearing disorders, making early detection essential for effective management.
What the Test Measures
This test utilizes Next Generation Sequencing (NGS) technology to analyze the GJB2 gene for mutations. It detects variations that may lead to KID syndrome, allowing healthcare providers to understand the genetic basis of the patient’s symptoms.
Who Should Consider This Test
Individuals exhibiting symptoms such as:
- Hearing loss
- Skin abnormalities
- Family history of similar symptoms
should consider this test. Risk factors include a family history of genetic disorders, particularly those affecting hearing and skin health.
Benefits of Taking the Test
- Early diagnosis allows for timely intervention and management.
- Provides valuable information for family planning and genetic counseling.
- Enhances understanding of the condition, leading to better treatment options.
Understanding Your Results
Results from the GJB2 Gene Keratitis Ichthyosis Deafness Syndrome Autosomal Dominant NGS Genetic DNA Test will be provided with a detailed report. It is important to discuss your results with a qualified healthcare provider to understand their implications and the next steps in your care.
Test Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| GJB2 Gene Keratitis Ichthyosis Deafness Syndrome Autosomal Dominant NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Booking the Test
To book the GJB2 Gene Keratitis Ichthyosis Deafness Syndrome Autosomal Dominant NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with scheduling your test and answering any questions you may have.
Turnaround time for results is approximately 3 to 4 weeks. Sample types accepted include blood, extracted DNA, or one drop of blood on an FTA card. Ensure you provide a clinical history and consider a genetic counseling session for comprehensive support.
